These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11064844)

  • 21. [The treatment of schizophrenia--improper choices, adverse events. Preliminary report].
    Marmurowska-Michałowska H; Wysocka A; Dubas-Slemp H; Kozak G
    Psychiatr Pol; 2002; 36(6 Suppl):217-23. PubMed ID: 12647442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Remission with long-lasting antipsychotic agent].
    Radics J
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):91-2. PubMed ID: 17970532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Principles of chemotherapy of paranoid schizophrenia].
    Vanelle JM; Loloum T
    Encephale; 1991; 17(4):235-40. PubMed ID: 1683623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Language regression to the mother tongue in polyglot patients with acute psychosis].
    Heinemann F; Assion HJ
    Nervenarzt; 1996 Jul; 67(7):599-601. PubMed ID: 8927199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia.
    Brizer DA; Hartman N; Sweeney J; Millman RB
    Am J Psychiatry; 1985 Sep; 142(9):1106-7. PubMed ID: 2862800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral edema associated with risperidone oral solution: a case report and a review of the literature.
    Yang HN; Cheng YM
    J Clin Psychopharmacol; 2012 Feb; 32(1):128-30. PubMed ID: 22217945
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Initiation of treatment with olanzapine in a patient hospitalized at UMD].
    Portier A; Christophe S
    Encephale; 2000; 26(3):69-71. PubMed ID: 10951908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G; Burghof KW; Kasper S; Möller HJ
    Nervenarzt; 1994 Mar; 65(3):202-5. PubMed ID: 7909917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in refractory psychosis with dronabinol: four case reports.
    Schwarcz G; Karajgi B
    J Clin Psychiatry; 2010 Nov; 71(11):1552-3. PubMed ID: 21114952
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of depersonalization-derealization syndrome during treatment with quetiapine.
    Sarkar J; Jones N; Sullivan G
    J Psychopharmacol; 2001 Sep; 15(3):209-11. PubMed ID: 11565631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socio-demographic and clinical profiles of paranoid and nonparanoid schizophrenia: a prospective, multicenter study in China.
    Xiang YT; Wang CY; Chiu HF; Weng YZ; Bo QJ; Chan SS; Lee EH; Ungvari GS
    Perspect Psychiatr Care; 2011 Jul; 47(3):126-30. PubMed ID: 21707627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid and Carbamazepine: a successful antipsychotic medication? The problem of diagnosis and its relevance for therapy.
    Gutiérrez K; Walter H; Bankier B
    Psychopathology; 1999; 32(5):235-41. PubMed ID: 10494062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone-reserpine combination in refractory psychosis.
    Solon EN
    Schizophr Res; 1996 Dec; 22(3):265-6. PubMed ID: 9000324
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of adjunctive novel antipsychotics with depot haloperidol.
    Sattar SP; Fernandes P; Bhatia SC
    Psychiatr Serv; 2003 Jul; 54(7):1040-1. PubMed ID: 12851447
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature.
    Mews MR; Quante A
    J Clin Psychopharmacol; 2013 Aug; 33(4):512-9. PubMed ID: 23771191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Improvement of verbal hallucinations after treatment of orolingual dyskinesia with tiapride].
    López Zanón A; Suárez Gisbert E; López San Román I
    Nervenarzt; 1993 Jan; 64(1):73-4. PubMed ID: 8094893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.